Biotech Showcase™ is an investor and networking conference devoted to providing private and small- and mid-cap biotechnology companies an opportunity to present to and meet with investors and biopharmaceutical executives during the course of one of the largest annual healthcare conferences that attracts investors and biopharmaceutical executives from around the world. The 2019 event showed a substantial increase in the number of presenting companies, as well as significant growth in the number of attendees and one-to-one meetings. Now in its twelfth year, Biotech Showcase 2020 is expected to feature presentations by over 400 public and private companies and attract more than 3,700 attendees, including 900 investors. The event will run a full program of topical plenary sessions and workshops, including special-focus events dedicated to emerging trends. The demand for innovation in all areas of human health is the impetus behind Digital Medicine & Medtech Showcase, a focus event taking place during Biotech Showcase at Parc 55 in San Francisco. The event brings together key stakeholders at the convergence of traditional therapeutics, digital tools, combination products, companion diagnostics, precision medicine, AI and other technical advances to explore funding opportunities, partnerships and collaboration. Biotech Showcase is co-produced by Demy-Colton Life Science Advisors and EBD Group. Both organizations have a long history of providing high quality business support services to the biotechnology industry.